21 May 2009
Portal flow – a reliable predictor of early liver graft function
M Pacholczyk, B Łągiewska, M Kosieradzki, W Lisik, G Gontarczyk, L Adadyński, A ChmuraAnn Transplant 2009; 14(1): 27-27 :: ID: 880296
Abstract
Background: Studies of factors responsible for early liver graft function were
conducted in our institution. Aim of the study was to identify most simple and useful test for predicting early liver graft function.
Material/Methods: Fifty-six livers were classified as transplantable based on
routine donor demographics, hemodynamic and biochemistry as well as
macroscopic assessment by the surgeon on retrieval. Moreover, portal, arterial and parenchymal hepatic blood flow as well as HE histology, ketone index, bile acids chromatography, arachidonic acid metabolites were also studied. Post-transplant early liver function was categorized based on modified Neuhaus classification (2 points assigned for each of: bile output <50ml/d, AST >1800 IU/L, ALT >1600 IU/L, INR >1.7 despite plasma infusions, poor initial function (PIF) was diagnosed with score >6).
Results: Of 56 patients, only 4 had PIF. No primary nonfunction was seen. Neither histology, nor biochemical tests proved useful in prediction of this
complication. Of multiple methods of flow assessment, portal blood flow (PF)
30 minutes after reperfusion was the most reliable factor. It differed significantly between good (GF) and poor initial function groups.
Keywords: Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






